GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BUE:LLY) » Definitions » E10

Eli Lilly and Co (BUE:LLY) E10 : ARS129.77 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ARS19,715.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ARS129.77 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 20.40% per year. During the past 3 years, the average E10 Growth Rate was 11.60% per year. During the past 5 years, the average E10 Growth Rate was 9.60% per year. During the past 10 years, the average E10 Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 13.50% per year. The lowest was -2.70% per year. And the median was 5.30% per year.

As of today (2025-03-19), Eli Lilly and Co's current stock price is ARS19025.00. Eli Lilly and Co's E10 for the quarter that ended in Dec. 2024 was ARS129.77. Eli Lilly and Co's Shiller PE Ratio of today is 146.61.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 39.11.


Eli Lilly and Co E10 Historical Data

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.72 106.06 204.53 615.68 129.77

Eli Lilly and Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 615.68 102.83 135.46 125.16 129.77

Competitive Comparison of Eli Lilly and Co's E10

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=19715.2/133.1571*133.1571
=19,715.200

Current CPI (Dec. 2024) = 133.1571.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201503 17.639 99.621 23.577
201506 20.354 100.684 26.919
201509 28.207 100.392 37.413
201512 22.409 99.792 29.901
201603 23.951 100.470 31.743
201606 39.702 101.688 51.988
201609 43.557 101.861 56.940
201612 44.455 101.863 58.113
201703 -6.167 102.862 -7.983
201706 62.654 103.349 80.725
201709 37.150 104.136 47.503
201712 -120.680 104.011 -154.497
201803 93.491 105.290 118.236
201806 -24.940 106.317 -31.236
201809 164.860 106.507 206.112
201812 160.532 105.998 201.664
201903 673.912 107.251 836.697
201906 257.351 108.070 317.093
201909 306.474 108.329 376.714
201912 373.477 108.420 458.689
202003 397.244 108.902 485.722
202006 424.452 108.767 519.630
202009 394.957 109.815 478.909
202012 720.330 109.897 872.792
202103 536.877 111.754 639.697
202106 579.748 114.631 673.442
202109 477.166 115.734 548.999
202112 731.163 117.630 827.680
202203 901.925 121.301 990.080
202206 505.386 125.017 538.294
202209 894.838 125.227 951.508
202212 1,367.550 125.222 1,454.212
202303 1,177.398 127.348 1,231.108
202306 1,872.000 128.729 1,936.399
202309 -83.988 129.860 -86.121
202312 3,494.480 129.419 3,595.402
202403 8,357.600 131.776 8,445.180
202406 11,748.960 132.554 11,802.434
202409 4,068.140 133.029 4,072.060
202412 19,715.200 133.157 19,715.200

Add all the adjusted EPS together and divide 10 will get our e10.


Eli Lilly and Co  (BUE:LLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=19025.00/129.77
=146.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 39.11.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.